Jazz Pharmaceuticals (JAZZ) was upgraded to a 'Buy' recommendation by TheStreet.com's quantitative service today. Let's check out the price charts and technical indicators to see if they are in agreement.
More from Investing
The Disney+ effect, regional subscriber growth and 2020 content spending and free cash flow guidance are among the things to track as the streaming giant reports.
Charts are far more valuable as a tool for trade and portfolio management.
Trying to fight the positive trend has been a disaster for the naysayers.
Last year wasn't particularly kind to every stock, but some are turning around for the better in 2020.